Project: Medtech Alliance for Global InternationAlisation
Duration: Project duration: 01/01/2018 – 31/12/2019
Coordinator: bioPmed

Project partners:

MAGIC: THE EUROPEAN PARTNERSHIP FOR THE INTERNATIONALIZATION OF MEDTECH SMES

The MAGIA, Medtech Alliance for Global Internationalization project was implemented within the European Union’s COSME program and involved four major European clusters operating in the medical and human health sector with the aim of promoting the internationalization of their companies.

The four clusters are the bioPmed Innovation Cluster, the Walloon cluster BioWin, Lyonbiopole from the Rhône-Alpes region of France, and Life Science Nord from the Hamburg region of Germany.

The aim of the MAGIA project was to strengthen the competitiveness of medical SMEs in two global target markets and to give greater visibility to the innovativeness of the European Medtech industry through international cooperation and resource sharing.

Among the emerging sectors, medical technology is considered among the most promising but also among the most difficult for small and medium-sized companies and start-ups to tackle. In Europe, SMEs in this sector often face a number of obstacles: strong and well-organized international competition, strict and complex regulations, the need to integrate different technologies, and a lack of time, funds and skilled personnel. The role of clusters is therefore crucial in supporting companies that want to enter international markets and providing them with the most appropriate tools.

Through cooperation and resource sharing at the European level, the Magia project aimed to strengthen the competitiveness of medical SMEs in two global target markets and to give greater visibility to the innovativeness of the European medtech industry.
The four clusters have pooled their knowledge, experience and best practices to achieve the critical mass needed to be the single point of reference for European medical companies.

Operationally, the project was developed over a 24-month time horizon and was divided into 5 separate but strategically consequential work-packages: from the analysis of the competitive environment, we will move on to the definition of the operational strategy and the identification of target markets, and finally to the implementation of training paths and representative missions useful for accompanying MedTech SMEs in international markets.

CHINESE AND AMERICAN MEDICAL DEVICE MARKET REPORT

bioPmed is pleased to announce the publication of the two reports on the Chinese and American medical device markets resulting from the MAGIA initiative, the European partnership for the internationalization of MedTech SMEs.

The market reports are designed to be able to provide a broad and detailed overview of the two foreign markets, the opportunities they may offer, and the best strategies for accessing them. Interested companies will also be able to find a detailed outline of the regulatory path to take.

The two market reports are available for download here:

Chinese market report

US market report

THE U.S. MEDICAL DEVICE MARKET: TRAINING TOOLS

bioPmed presents a series of new and tools to better address the U.S. medical device market.

Along with the already published Report on the U.S. market, a series of training videos are now available that go into different aspects of the internationalization process for medical companies:

CHINA’S MEDICAL DEVICE MARKET: TRAINING TOOLS

Along with the already published Report on the Chinese market, a series of training videos are now available that go into different aspects of the internationalization process for medical companies:

MAGIC: A RECAP OF THE ACTIVITIES SO FAR

The MAGIA project team would like to take this opportunity to reveal to the SME community and other interested individuals what steps have been taken along the course of this project and what outcomes have already been generated
THROUGH MAGIC.

Find here the MAGIA – Foreign expert training program.